Presentations

Investor Presentation

Corporate Presentation

Corporate Presentation

Corporate Presentation

Next Generation Chemotherapy: Improved Treatment for More Patients

Benefit-Risk Analysis for FDA Approval Requires More Than a Pivotal Trial

Investor Presentation

Next Generation Chemotherapy: Improved Treatment for More Patients

Applying FDA’s Project Optimus to the Development of Next Generation Chemotherapy Treatment of Rare Cancers – WODC May 24, 2023

Digestive Disease Week Presentation